News in English
Enter any phrase or word you would like to search for and click .
PostNews: Press Release
University of California, San Francisco and Phase Holographic Imaging establish Center of Excellence
University of California, San Francisco (UCSF) and Phase Holographic Imaging (PHI) have agreed to expand their on-going collaboration and establish a regional Holographic Imaging Cytometry Center of Excellence, located at the UCSF Helen Diller Family Comprehensive Cancer Center.
Learn more …
PostNews: Press Release
Novel HoloMonitor method identifies tumor creating cancer cells
Using HoloMonitor®, researchers at Harvard Medical School and Boston Children’s Hospital have developed a novel non-invasive method for distinguishing between active and dormant cancer cells.
Learn more …
PostPress Release
New CEO commentary: “The scientific role of commercialization”
On PHI’s website, founder and CEO Peter Egelberg comments on his presentation at SPIE 2018 in San Francisco “The evolution of Phase Holographic Imaging from a research idea to publicly traded company”, see CEO commentary The scientific role of commercialization, published February 18, 2018.
Learn more …
PostPress Release
PHI and Germany’s federal institute for materials research pursue joint patent application
Phase Holographic Imaging (PHI) and Germany’s federal institute for materials research (BAM) has agreed to jointly enter the national phase of international patent application “Molecularly Imprinted Polymers” in Europe, USA, China and Japan. An international patent application is a preliminary review prior to national applications. Patents are only granted nationally.
Learn more …
PostNews: Press Release
PHI Launches Wound Healing Assay
HoloMonitor® Wound Healing Assay: The assay meets the unmet market demand of both quantifying cell movement automatically and in great detail. Wound healing assays are one of the most used laboratory methods to study cell movement. Conventional wound healing assays are either manual or just measure the collective movement of a cell population.
Learn more …
PostPress Release
Option Exercised IV
Phase Holographic Imaging (PHI) has two option programs, both with a final subscription date of October 24, 2017. The programs, directed to board members and advisors of the Company, were implemented as the Company was listed at AktieTorget.
Learn more …